Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis

International Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages

  Aziz, Hafsa ^a   Raza, Abida ^a   Murtaza, Shahnaz ^a   Waheed, Yasir ^b   Khalid, Ali ^a   Irfan, Javaid ^a   Samra, Zahoor ^c   Athar, Muhammad Amin ^c  

^a PAKISTAN ATOMIC ENERGY COMMISSION   (Pakistan)

^b NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

^c UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

Genotypes; Hepatitis C virus; NS5B gene; Phylogenetic analysis

Indexed keywords

ADULT; ARTICLE; BINDING SITE; CATALYSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAKISTAN; PHYLOGENY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAKISTAN; PHYLOGENY; YOUNG ADULT;

EID: 84875364807     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.09.017     Document Type: Article

References (30)

1. Aziz H., Gil M.L., Waheed Y., Adeeb U., Raza A., Bilal I., Athar M.A. Evaluation of prognostic factors for peg interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan. Infect Genet Evol 2011, 11:640-645.
2. Wands J.R. Prevention of hepatocellular carcinoma. N Engl J Med 2004, 351:1567-1570.
3. The C. Everett Koop Institute, Dartmouth College. Hepatitis C: an epidemic for anyone. Worldwide prevalence. Hanover, NH: The C. Everett Koop Institute; 2012. Available at: (accessed October 2012). http://www.epidemic.org/thefacts/theepidemic/worldPrevalence/.
4. McCaughan G.W., Omata M., Amarapurkar D., Bowden S., Chow W.C., Chutaputti A., et al. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol 2007, 22:615-633. Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party.
5. Waheed Y., Tahir S., Ahmad T., Qadri I. Sequence comparison and phylogenetic analysis of core gene of hepatitis C virus from Pakistani population. African Journal of Biotechnology 2010, 9:4561-4567.
6. Hamid S., Umar M., Alam A., Siddiqui A., Qureshi H., Butt J., et al. PSG Consensus Statement on management of hepatitis C virus infection-2003. J Pak Med Assoc 2004, 54:146-150.
7. Luby S.P., Qamruddin K., Shah A.A., Omair A., Pahsa O., Khan A.J., et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection at Hafizabad. Epidemiol Infect 1997, 119:349-356.
8. Pasha. Infection with HCV in families of hepatitis C positive patients living together. Paper presented at the Second Annual Symposium of Aga Khan University, October 1995. Karachi: The Doctors Fortnightly; 1997.
9. National Hepatitis Control Programme 2006, Ministry of Health, Government of Pakistan, Islamabad.
10. Tanaka T., Kato N., Nakagawa M., Ootsuyama Y., Cho M.J., Nakazawa T., et al. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res 1992, 23:39-53.
11. Okamoto H., Kojima M., Okada S., Yoshizawa H., Iizuka H., Tanaka T., et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992, 190:894-899.
12. Zein N.N., Rakela J., Krawitt E.L., Reddy K.R., Tominaga T., Persing D.H. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996, 125:634-639.
13. Takada N.S., Takase S., Takada A. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993, 17:277-283.
14. Tsubota A., Chayama K., Ikeda K., Yasuji A., Koida I., Saitoh S., et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994, 19:1088-1094.
15. Ohno T., Mizokami M., Wu R., Saleh M.G., Ohba K., Orito E., et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997, 35:201-207.
16. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
17. Davis G.L., Esteban-Mur R., Rustgi V., Hoefs J., Gordon S.C., Trepo C., et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998, 339:1493-1499.
18. EASL International Consensus Conference on Hepatitis C. Paris, 26-28 February 1999, Consensus Statement. European Association for the Study of the Liver. J Hepatol 1999;30:956-61.
19. Attaullah S., Khan S., Ali I. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol J 2011, 8:433.
20. Idrees M., Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8:69.
21. Zuberi S.J., Arif A. Serotyping of hepatitis C in Pakistan. J Pak Med Assoc 2002, 52:218-219.
22. Das B.R., Kundu B., Khandapkar R., Sahni S. Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 2002, 45:323-328.
23. Tokita H., Shrestha S.M., Okamoto H., Sakamoto M., Horikita M., Iizuka H., et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 1994, 75:931-936.
24. Narahari S., Juwle A., Basak S., Saranath D. Prevalence and geographic distribution of hepatitis C virus genotypes in Indian patient cohort. Infect Genet Evol 2009, 9:643-645.
25. Shah H.A., Jafri W.S., Malik I., Prescott L., Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol 1997, 12:758-761.
26. Sarwar M.T., Kausar H., Ijaz B., Ahmad W., Ansar M., Sumrin A., et al. NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b. Virol J 2011, 8:317.
27. Zali M.R., Mayumi M., Raoufi M., Nowroozi A. Hepatitis C virus genotypes in the Islamic Republic of Iran: a preliminary study. East Mediterr Health J 2000, 6:372-377.
28. Butt S., Idrees M., Ur Rehman I., Akbar H., Shahid M., Afzal S., et al. Mixed genotype infections with hepatitis C virus, Pakistan. Emerg Infect Dis 2011, 17:1565-1567.
29. Oh J.W., Ito T., Lai M.C. Recombinant hepatitis C virus RNA dependent RNA polymerase capable of copying the full-length viral RNA. J Virol 1999, 73:7694-7702.
30. Qin W., Yamashita T., Shirota Y., Lin Y., Wei W., Murakami S. Mutational analysis of the structure and function of hepatitis C virus RNA-dependent RNA polymerase. Hepatology 2001, 33:728-737.